Sarissa Capital Management LP — 13F Holdings & Portfolio

CIK 1577524 · latest 13F-HR filed 2026-05-15

Sarissa Capital Management LP manages $157.6M in 13F-reported U.S. long-equity assets across 9 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are INVA (31.50%), IRWD (20.46%), AMRN (15.35%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 0, added to 1, and trimmed 5.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$157.6M

Long-equity book

Holdings

9

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+0 / −0 / ↑1 / ↓5

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • VOR BIOPHARMA INC$120.9K +36.4%
Show all 1

Top Trims

  • NEUROCRINE BIOSCIENCES INC-$27.6M -64.3%
  • IRONWOOD PHARMACEUTICALS INC-$21.4M -39.9%
  • CYTOKINETICS INC-$10.1M -40.2%
  • INNOVIVA INC-$6.6M -11.8%
  • BIOHAVEN LTD-$1.0M -17.8%
Show all 5

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 INNOVIVA INC INVA 45781M101 $49.7M 31.50% 2,130,950 SH
2 IRONWOOD PHARMACEUTICALS INC IRWD 46333X108 $32.3M 20.46% 9,188,635 SH
3 AMARIN CORP PLC AMRN 023111404 $24.2M 15.35% 1,673,395 SH
4 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $15.4M 9.74% 116,533 SH
5 CYTOKINETICS INC CYTK 23282W605 $15.1M 9.56% 228,623 SH
6 LANTHEUS HLDGS INC LNTH 516544103 $12.7M 8.03% 166,919 SH
7 BIOHAVEN LTD BHVN G1110E107 $4.8M 3.02% 563,184 SH
8 REGENERON PHARMACEUTICALS REGN 75886F107 $3.2M 2.05% 4,190 SH
9 VOR BIOPHARMA INC VOR 929033207 $453.1K 0.29% 25,399 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $157.6M 9 0000899140-26-000574
2025-12-31 2026-02-17 $222.9M 9 0000899140-26-000256
2025-09-30 2025-11-14 $180.4M 8 0000899140-25-001320